Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity

Journal of Experimental Medicine

Volumn 195, Issue 5, 2002, Pages

  Bendelac, Albert ^a   Medzhitov, Ruslan ^b  

^a PRINCETON UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FUNCTION; CELLULAR IMMUNITY; IMMUNE RESPONSE; IMMUNITY; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADAPTATION, PHYSIOLOGICAL; ADJUVANTS, IMMUNOLOGIC; ANIMALS; DENDRITIC CELLS; DROSOPHILA PROTEINS; GALACTOSYLCERAMIDES; HUMANS; IMMUNITY, NATURAL; MEMBRANE GLYCOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; TOLL-LIKE RECEPTORS;

EID: 0037018097     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (42)

1. Sensitization to horse serum by means of adjuvants
2. Approaching the asymptote? Evolution and revolution in immunology
3. The instructive role of innate immunity in the acquired immune response
4. Innate immunity: The virtues of a nonclonal system of recognition
5. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines
6. Autoreactivity by design: Innate B and T lymphocytes
7. Inaugural Article: Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
8. Toll-like receptors: Critical proteins linking innate and acquired immunity
9. The evolution and genetics of innate immunity
10. The role of Toll-like receptors in host defense against microbial infection
11. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in drosophila adults
12. Toll-like receptors control activation of adaptive immune responses
13. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein
14. TIRAP: An adapter molecule in the Toll signaling pathway
15. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
16. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes
17. CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav
18. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
19. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the sponge Agelas mauritianus
20. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
21. Cutting edge: Activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
22. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
23. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)- 12 production by dendritic cells and IL-12 receptor expression on NKT cells
24. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
25. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
26. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
27. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
28. Natural killer T cell activation inhibits hepatitis B virus replication In vivo
29. Alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria
30. Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with alphagalactosylceramide
31. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
32. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes
33. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
34. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis
35. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes
36. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis
37. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells
38. Natural adjuvants: Endogenous activators of dendritic cells
39. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
40. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway
41. An innate sense of danger
42. Tolerance, danger and the extended family